This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
An Orally Bioavailable Drug Candidate for Spinal Muscular Atrophy
Investments > €500k
United States of America
Spinal muscular atrophy (SMA)
2016